@article{63ae9d25ed8c443d93d585691d3e1b8f,
title = "The COVID-19 Pandemic and Post-Infection Irritable Bowel Syndrome: What Lies Ahead for Gastroenterologists",
author = "Chan, {Walter W.} and Madhusudan Grover",
note = "Funding Information: Funding Madhusudan Grover is supported by the National Institutes of Health (DK 127998). Funding Information: Conflicts of interest The authors disclose the following: Walter W. Chan served on the scientific advisory board for Ironwood, Takeda, and Phathom Pharmaceuticals. Madhusudan Grover has received research support from Takeda, Donga, and Alexza Pharmaceuticals; and served as advisor for Alfasigma pharmaceuticals.Funding Madhusudan Grover is supported by the National Institutes of Health (DK 127998).",
year = "2022",
month = oct,
doi = "10.1016/j.cgh.2022.05.044",
language = "English (US)",
journal = "Clinical Gastroenterology and Hepatology",
issn = "1542-3565",
publisher = "W.B. Saunders Ltd",
}